NovoCure (NVCR) Competitors

NovoCure (NASDAQ:NVCR) and ICU Medical (NASDAQ:ICUI) are both mid-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, community ranking, risk, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

Do analysts rate NVCR or ICUI?

NovoCure presently has a consensus target price of $30.88, indicating a potential upside of 42.61%. ICU Medical has a consensus target price of $123.00, indicating a potential upside of 21.11%. Given NovoCure's higher possible upside, research analysts plainly believe NovoCure is more favorable than ICU Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NovoCure	0 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.56
ICU Medical	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has preferable valuation and earnings, NVCR or ICUI?

ICU Medical has higher revenue and earnings than NovoCure. ICU Medical is trading at a lower price-to-earnings ratio than NovoCure, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NovoCure	$509.34M	4.58	-$207.04M	-$1.81	-11.98
ICU Medical	$2.26B	1.09	-$29.66M	-$2.45	-41.39

Does the media refer more to NVCR or ICUI?

In the previous week, NovoCure had 2 more articles in the media than ICU Medical. MarketBeat recorded 8 mentions for NovoCure and 6 mentions for ICU Medical. ICU Medical's average media sentiment score of 1.73 beat NovoCure's score of 0.89 indicating that ICU Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NovoCure	2 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
ICU Medical	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Do insiders and institutionals hold more shares of NVCR or ICUI?

84.6% of NovoCure shares are held by institutional investors. Comparatively, 96.1% of ICU Medical shares are held by institutional investors. 6.3% of NovoCure shares are held by insiders. Comparatively, 6.7% of ICU Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Does the MarketBeat Community believe in NVCR or ICUI?

NovoCure received 84 more outperform votes than ICU Medical when rated by MarketBeat users. However, 64.48% of users gave ICU Medical an outperform vote while only 63.71% of users gave NovoCure an outperform vote.

Company	Underperform	Outperform
NovoCure	Outperform Votes 467 63.71%	Underperform Votes 266 36.29%
ICU Medical	Outperform Votes 383 64.48%	Underperform Votes 211 35.52%

Which has more risk and volatility, NVCR or ICUI?

NovoCure has a beta of 0.5, indicating that its stock price is 50% less volatile than the S&P 500. Comparatively, ICU Medical has a beta of 0.72, indicating that its stock price is 28% less volatile than the S&P 500.

Is NVCR or ICUI more profitable?

ICU Medical has a net margin of -2.63% compared to NovoCure's net margin of -36.67%. ICU Medical's return on equity of 5.38% beat NovoCure's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NovoCure	-36.67%	-50.35%	-16.86%
ICU Medical	-2.63%	5.38%	2.58%

Summary

ICU Medical beats NovoCure on 11 of the 18 factors compared between the two stocks.